Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
EYPT
Stock Latest News
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
16d ago
EYPT
Premium
Company Announcements
EyePoint Pharma’s Earnings Call: Clinical Progress Amid Financial Challenges
27d ago
EYPT
Premium
Ratings
EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
27d ago
EYPT
Premium
Company Announcements
EyePoint Pharmaceuticals Reports 2024 Financial Results
27d ago
EYPT
Premium
The Fly
EyePoint reports Q4 EPS (64c), consensus (48c)
28d ago
EYPT
Premium
The Fly
EyePoint expects cash to fund operations into 2027
28d ago
EYPT
Premium
Pre-Earnings
Eyepoint Pharma (EYPT) Q4 Earnings Cheat Sheet
1M ago
EYPT
Premium
Ratings
EyePoint Pharmaceuticals: Buy Rating Backed by Promising Duravyu Phase 2 Results and Growth Potential in Undervalued Market
2M ago
EYPT
Premium
Ratings
EyePoint Pharmaceuticals: An Undervalued Opportunity Amid Market Overreaction and Financing Concerns
2M ago
EYPT
Premium
The Fly
Collegium appoints Nancy Lurker to board of directors
2M ago
COLL
EYPT
Premium
The Fly
EyePoint announces Phase 2 VERONA trial met primary endpoint
2M ago
EYPT
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
3M ago
EYPT
Premium
The Fly
EyePoint provides company update, anticipated milestones
3M ago
EYPT
Premium
Company Announcements
EyePoint Pharmaceuticals Strengthens Board with New Appointment
3M ago
8K
EYPT
Premium
The Fly
EyePoint appoints Reginald Sanders to board of directors
3M ago
EYPT
Premium
The Fly
EyePoint initiated with a Buy at Citi
3M ago
EYPT
OCUL
Premium
The Fly
Short Report: Sunrun bears add to exposure for third straight week
3M ago
RUN
SVV
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
4M ago
EYPT
Premium
The Fly
EyePoint doses first patient in second Phase 3 LUCIA clinical trial
4M ago
EYPT
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
5M ago
EYPT
Premium
The Fly
EyePoint price target lowered to $22 from $30 at H.C. Wainwright
5M ago
EYPT
Premium
The Fly
EyePoint price target lowered to $33 from $38 at Baird
5M ago
EYPT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
